Postexposure prophylaxis after sexual assaults: A prospective cohort study

Sexually Transmitted Diseases

Volumn 32, Issue 4, 2005, Pages 214-219

  Garcia, Márcia Teixeira ^a   Figueiredo, Rosely Moralez ^b   Moretti, Maria Luiza ^a   Resende, Máriangela Ribeiro ^a   Bedoni, Aloísio J ^a   Papaiordanou, Priscila Maria O ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; LAMIVUDINE; NELFINAVIR; ZIDOVUDINE;

ADULT; ASTHENIA; COHORT ANALYSIS; DIZZINESS; DYSPEPSIA; EXPOSURE; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; NAUSEA; NEPHROLITHIASIS; PATIENT COMPLIANCE; PRESCHOOL CHILD; PROPHYLAXIS; PROSPECTIVE STUDY; RAPE; RASH; REVIEW; RISK ASSESSMENT; SCHOOL; SCHOOL CHILD; SEROCONVERSION; SEXUAL CRIME; SIDE EFFECT; STEVENS JOHNSON SYNDROME; VIRUS TRANSMISSION; VOMITING;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; BRAZIL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HUMANS; INDINAVIR; LAMIVUDINE; MALE; MIDDLE AGED; NELFINAVIR; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RAPE; SEXUALLY TRANSMITTED DISEASES; ZIDOVUDINE;

EID: 15744399834     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000149785.48574.3e     Document Type: Review

References (38)

1. Tsai CC, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl) adenine. Science 1995; 270:1197-1199.
2. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996; 335:1621-1629.
3. Cardo DM, Culver DH, Ciessielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997; 337:1542-1543.
4. Centers for Disease Control and Prevention. Update. US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for post-exposure prophylaxis. MMWR Morb Mortal Wkly Rep 2001; 50(RR-11):1-42.
5. Centers for Disease Control and Prevention. Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. MMWR Morb Mortal Wkly Rep 1998; 47(RR-17):1-14.
6. Myles JE, Bamberger J. Offering HIV prophylaxis following sexual assault: Recommendations for the state of California, 2001. Available at: http://hivinsite.ucsf.edu/pdf/pepassault.pdf. Accessed May 26, 2002.
7. Laporte A, Jourdan N, Bouvet E, et al. Post-exposure prophylaxis after non-occupational HIV exposure: Impact of recommendations on physicians' experiences and attitudes. AIDS 2002; 16:397-405.
8. Cohen MS, Eron JJ. Sexual HIV transmission and its prevention. HIV Medscape HIV/AIDS Clinical Management Modules, vol 18. HIV/ AIDS Medscape Home Page. Available at: www.medscape.com/ Medscape/HIV/ClinicalMgmt/CM.v18/public/ index-CM.v18.html. Accessed August 28, 2001.
9. Kahn JO, Martin JN, Roland ME, et al. Feasibility of post-exposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP study. J Infect Dis 2001; 183:707-714.
10. Katz M, Gerberding JL. The care of persons with recent sexual exposure to HIV. Ann Intern Med 1998; 128:306-312.
11. Fong C. Post-exposure prophylaxis for HIV infection after sexual assault: When is it indicated? Emerg Med J 2001; 18:242-245.
12. Grupo de Consenso Español sobre Profilaxis Postexposición No Ocupacional al VIH. Recommendations for non-occupational postexposure prophylaxis for HIV. Enferm Infecc Microbiol Clin 2002; 20:391-400.
13. Almeda J, Casabona J, Simon B, et al. Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe. Available at: http://www.eurosurveillance.org/em/ v09n06/0906-223.asp. Accessed August 14, 2004.
14. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998; 47(RR-1):1-116.
15. Fleming D, Wasserheit J. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
16. Cummins J Jr, Dezzutti CS. Sexual HIV-1 transmission and mucosal defense mechanisms. AIDS Rev 2000; 2:144-154.
17. Nicolosi A, Correa Leite M, Musicco M, et al. The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: A study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. Epidemiology 1994; 5:570-575.
18. Padian N, Shiboski S, Glass S, et al. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: Results from a ten-year study. Am J Epidemiol 1997; 146:350-357.
19. Vittinghoff E, Douglas J, Judson F, et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999; 150:306-311.
20. Mastro TD, de Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS 1996; 10(suppl A):S75-S82.
21. mne depends critically on timing of initiation and duration of treatment. J Virol 1998; 72:4265-4273.
22. Skov T, Deddens J, Petersen MR, et al. Prevalence proportion ratios: Estimation and hypothesis testing. Int J Epidemiol 1998; 27:91-95.
23. Kerr E, Cottee C, Chowdhury R, Jawad R, Welch J. The Haven: A pilot referral centre in London for cases of serious sexual assault. Br J Obstet Gynaecol 2003; 110:267-271.
24. Limb S, Kawsar M, Forster GE. HIV post-exposure prophylaxis after sexual assault: The experience of a sexual assault service in london. Int J STD AIDS 2002; 13:602-605.
25. Meel BL. HIV/AIDS Post-exposure prophylaxis for victims of sexual assault attending Umtata General Hospital, South Africa. In: XV International AIDS Conference Bangkok, Thailand, 2004. Med Gen Med 2004; 6:WePeB5847.
26. Vitavasiri C, Kendornfake S, Tapanayantra M, et al. Post exposure prophylaxis of HIV infection in sexually abused children. In: XV International AIDS Conference Bangkok, Thailand, 2004. Med Gen Med 2004; 6:TuPeC4747.
27. Roland ME, Martin JN, Grant RM, et al. Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: Identification and characterization of the source of exposure. J Infect Dis 2001; 184:1608-1612.
28. Coombs RW, Speck CE. Hughes JP, et al. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 1998; 177:320-330.
29. Hart C, Lennox J, Pratt-Palmore M, et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 1999; 179:871-882.
30. Cohen M, Hoffman I, Royce R, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implication for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 1997; 349:1868-1873.
31. Uvin S, Hogan J, Caliendo A, et al. Bacterial vaginosis decreases suppression of female genital tract HIV-1 RNA levels [Abstract 678]. In: 7th Conference on Retroviruses and Opportunistic Infections; San Francisco, CA; 2000.
32. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomized controlled trial. Lancet 1995; 346:530-536.
33. Gostin LO, Lazzarini Z, Alexander D, et al. HIV testing, counseling, and prophylaxis after sexual assault. JAMA 1994; 271:1436-1444.
34. Gore SM, Bird AG, Burns S, et al. Anonymous HIV surveillance with risk factor elicitation: At Perth (for men) and Cornton Vale (for women) prisons in Scotland. Int J STD AIDS 1997; 8:166-175.
35. Holmes MM, Resnick HS, Frampton D. Follow-up of sexual assault victims. Am J Obstet Gynecol 1998; 179:336-342.
36. Silberman B, Salmon D, Questel F, et al. Anti HIV chemoprophylaxis in the context of accidental sexual exposure by rape [Abstract 227]. 8th Conference on Retroviruses and Opportunistic Infections; Chicago; 2001.
37. Soussy A, Launay O, Aubert M, Caudron J. Post sexual exposure prophylaxis with HAART after sexual assaults [Abstract 228]. 8th Conference on Retroviruses and Opportunistic Infections; Chicago; 2001.
38. National Victim Center, Crime Victims Research and Treatment Center. Rape in America: A Report to the Nation. Charleston, SC: National Victim Center and Crime Victims Research and Treatment Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 1992:287.